Activation of the laryngeal mucosa results in apnea that is mediated through, and can be elicited via electrical stimulation of, the superior laryngeal nerve (SLN). This potent inhibitory reflex has been suggested to play a role in the pathogenesis of apnea of prematurity and SIDS and is attenuated by theophylline and blockade of GABA A receptors. However, the interaction between GABA and adenosine in the production of SLN stimulation induced apnea has not been previously examined. We hypothesized that activation of adenosine A 2A receptors will enhance apnea induced by SLN stimulation while subsequent blockade of GABA A receptors will reverse the effect of A 2A receptor activation. The phrenic nerve responses to increasing levels of SLN stimulation were measured before and after sequential intracisternal administration of adenosine A 2A receptor agonist CGS (n=10) and GABA A receptor blocker bicuculline (n=7) in ventilated, vagotomized, decerebrate and paralyzed newborn piglets. Increasing levels of SLN stimulation caused progressive inhibition of phrenic activity and lead to apnea during higher levels of stimulation. CGS caused inhibition of baseline phrenic activity, hypotension and enhancement of apnea induced by SLN stimulation. Subsequent bicuculline administration reversed the effects of CGS and prevented the production of apnea when compared to control at higher SLN stimulation levels. We conclude that activation of adenosine A 2A receptors enhances SLN stimulation induced apnea probably via a GABAergic pathway. We speculate that SLN stimulation causes endogenous release of adenosine that activates A 2A receptors on GABAergic neurons resulting in the release of GABA at inspiratory neurons and subsequent respiratory inhibition.
Introduction:
Activation of the laryngeal mucosa either chemically-through instillation of water or acid-or mechanically results in apnea that is usually associated with adduction of upper airways and swallowing movements. This potent inhibitory reflex apnea, traditionally termed the laryngeal chemoreflex, has been well characterized in newborn infants (24, 25) and animals of different species and is mediated through the superior laryngeal nerve (SLN), a branch of the vagus nerve. Electrical stimulation of the SLN can induce a similar apneic response. The laryngeal chemoreflex is developmentally regulated as it is strongest in newborns (21) and has been proposed to play a role in the pathogenesis of apnea of prematurity (25), gastro-esophageal reflux induced apnea (17) and Sudden Infant Death Syndrome (6, 33) . However, the exact mechanisms, neuronal connections and neurotransmitters involved in this response have not been well characterized.
The maturation of reflex apnea in piglets is very well described, and newborn animals are known to exhibit an exaggerated response to laryngeal stimulation (18) . We have established in our previous studies the involvement of -Aminobutyric Acid (GABA) in SLN stimulation induced apnea. Blockade of GABA A receptors through 4 between adenosine and GABA during regulation of breathing and sleep. We have reported that blockade of GABA A receptors abolishes the inhibitory effect of the adenosine A 2A agonist CGS21680 on phrenic activity in piglets (34) . Additionally, A 2A receptors were found to colocalize with GABAergic neurons in the medulla oblongata of both piglets (34) and rats (35) . Furthermore, activation of adenosine A 2A receptors caused increased release of GABA in the tuberomammillary nucleus of rats (13) . These data together with the ability of both bicuculline and theophylline to block SLN stimulation induced apnea raise the possibility of an interaction between GABA and adenosine in the pathogenesis of this inhibitory reflex response, although such interaction
has not yet been described.
We hypothesized that 1) activation of central adenosine A 2A receptors will enhance the inhibition of phrenic activity induced by SLN stimulation and allow apnea to occur at lower levels of electrical stimulation and 2) subsequent blockade of GABA A receptors will reverse the effects of activation of adenosine A 2A receptors. In this study we aimed to test this hypothesis by 1) examining the effect of intracisternal administration of the adenosine A 2A receptor agonist CGS21680 (CGS) on SLN stimulation induced apnea and 2) evaluating the effect of subsequently administering the GABA A receptor antagonist bicuculline on this response in the newborn piglet.
Materials and Methods:
All experimental procedures were approved by the Institutional Animal Care and Use Committee of Case Western Reserve University School of Medicine. The experiments were performed in 3-7 day old piglets (n=10), a well identified model for studying laryngeal reflex apnea. The average weight of the animals was 2.1±0.1 kg. The animals Page 4 of 32 were initially sedated with an intramuscular mixture of xylazine (2.8 mg/kg) and ketamine (14.4 mg/kg), followed by intravenous thiopental at a dose of 25-30 mg/kg. The trachea was intubated through a cervical tracheostomy and the animals were placed on a volume controlled ventilator (Harvard Apparatus). The volume and frequency of tidal breaths were adjusted to keep a stable eucapneic PaCO 2 of 35-45 mmHg, using an end tidal CO 2 analyzer, while using an inspired O 2 concentration of 100%. Femoral venous and arterial lines were inserted for administration of fluid and medication, and blood pressure monitoring and blood gas analysis, respectively.
To avoid the known confounding effects of anesthesia on breathing and laryngeal reflex apnea (8, 18, 21) , midcollicular decerebration was performed as previously described in newborn piglets (1, 5) . Anesthesia was discontinued after decerebration was completed and the animals were allowed to recover for at least one hour following the surgical preparation before any experimental recordings were performed. Gallamine triethiodide (10 mg/kg/hour) was used for paralysis.
Both vagal nerves were identified and cut in the caudal cervical area, below the origin of the SLNs in order to avoid the effect of lung inflation and other afferent pulmonary inputs on respiratory timing. The phrenic nerve was dissected, sectioned, desheathed and placed on a bipolar recording electrode. The phrenic nerve electroneurogram (ENG) was amplified (P511, Grass Instruments), rectified, and the moving average signal was connected to an analog computer. The SLN on one side was identified, dissected, sectioned, desheathed and placed on a bipolar electrode connected to a stimulator (S11, Grass Instruments). We defined SLN threshold, as the minimal amount of electrical current needed to decrease phrenic nerve amplitude or frequency.
The electrical current needed to induce threshold stimulation averaged 6.6±0.6 with a range of 4 to 11 microamperes. Fifteen seconds of SLN stimulation was performed at threshold, 1.5, 2, and 4 times threshold using impulses with pulse duration of 4.5 microseconds and pulse interval of 50 microseconds applied through a photoelectric isolation unit (PSIU6, Grass Instruments).
The animals were placed prone, the back of the neck dissected and muscles separated in the midline. The occipito-atlantic membrane was visualized and the tip of a 10-15 cm, 25 gauge soft venous catheter was inserted through the membrane. Proper placement was confirmed by CSF leak. The phrenic nerve response to multiple levels of SLN stimulation was measured at baseline and after sequential intracisternal administration of: A) 0.1-0.3 ml of DMSO-the vehicle for CGS (n=6), B) 0.1-0.3 ml of a 10 micromolar solution of adenosine A 2A receptor agonist CGS (n=10) and C) 0.1-0.2 ml of 1mg/ml solution of the GABA A receptor blocker bicuculline (n=7). These concentrations were chosen based on the minimal dose needed to cause a consistent effect from our previous studies in piglets (1, 34) . The average duration between CGS and bicuculline administration was 118±18 minutes. This represented the duration needed for adjustment of ventilator rate to allow for recovery of phrenic activity following CGS administration plus the duration of the SLN stimulation.
Data collection and statistical analysis:
We used PowerLab hardware and Chart software (both from AD Instruments, CA) to capture signals in real-time (2 kHz sampling rate).
Blood pressure, full wave rectified and moving averaged phrenic neurogram were recorded as well as airway CO 2 during both inspiration and expiration. The integrated moving average of phrenic nerve activity was analyzed for phrenic area, frequency, inspiratory (T I ) and expiratory times (T E ) and minute activity (phrenic area times frequency). All phrenic parameters were averaged for one minute during baseline (before any intervention), thirty seconds preceding each SLN stimulation and the fifteen second duration of each SLN stimulation at threshold, 1.5, 2 and 4 times threshold. Data are presented as mean±SEM of normalized values relative to pre-stimulation levels (average value during 15 seconds of stimulation/average value during 30 seconds preceding stimulation X 100%). The effect of the administered chemical on the phrenic activity was also normalized to values prior to administration using the above formula. Apnea was defined as doubling of T E when compared to baseline.
Repeated measures two way ANOVA was used to compare the effect of CGS and bicuculline on the phrenic response to SLN with post-hoc comparisons using Student Neuman-Keuls test. One-way ANOVA was used to evaluate the effect of different interventions on phrenic minute activity, frequency, tidal volume as well as mean arterial blood pressure, heart rate and arterial PaCO 2 levels after different interventions.
Pearson's coefficient (p) value of less than 0.05 was used for statistical significance.
Results:
SLN stimulation: As we have previously described, SLN stimulation caused a decrease in phrenic area, frequency and minute phrenic activity that was proportional to the level of stimulation. The decrease in phrenic frequency was secondary to a significant prolongation of the expiratory time (T E ) while there was a significant shortening of inspiratory time (T I ) with increasing stimulation secondary to the occurrence of apnea (Table 1) . The incidence and duration of apnea in response to SLN stimulation also increased in response to higher levels of stimulation, Table 1 .
DMSO (CGS vehicle):
In the first six animals the phrenic responses to graded SLN stimulation were measured following intracisternal administration of DMSO, the vehicle for CGS. Phrenic nerve responses to SLN stimulation following DMSO were identical to those of the control period. Therefore, in the last four animals this step was omitted. The responses to CGS and bicuculline administration in all animals presented hereafter were compared to the control levels. respectively. Even after lowering PaCO 2 to control levels, bicuculline still caused a significant increase in phrenic area to 192±50%, p<0.05, when compared to prebicuculline, post-CGS levels while phrenic frequency and minute phrenic activity did not change, 79±10% and 135±21 % respectively, NS. However, phrenic area, frequency and minute activity following bicuculline were not different from control, pre-CGS levels; i.e. bicuculline blocked the effects of CGS and returned phrenic activity toward control values. Following bicuculline administration the phrenic area, frequency and minute activity were 83±14%, 89±8% and 77±16% respectively when compared to control pre-CGS levels, NS.
2. The effect on blood pressure and heart rate: Intracisternal bicuculline caused recovery of MAP toward control, pre-CGS levels. The MAP was 50±5.9 mm Hg following bicuculline, p <0.01 and 0.71 versus CGS and control respectively. However, the tachycardia seen after CGS continued following bicuculline administration despite recovery of blood pressure. The heart rate was 287±6 BPM following bicuculline, significantly higher than control, p<0.001 but not different from CGS, p=0.13. Activation of adenosine A 2A receptors with CGS exaggerated the inhibitory effects of SLN stimulation on phrenic responses despite the hypercapnia that was needed to recover phrenic activity following CGS administration. This is of particular interest as hypercapnia increases the threshold for the production of the laryngeal chemoreflex (16, 19) i.e. the same level of SLN stimulation causes less inhibition of phrenic activity in the presence of hypercapnia. Another confounding variable that might have affected our results is the decrease in blood pressure following CGS administration. Although hypotension is part of the laryngeal chemoreflex in the intact animal we are not familiar with any reports that link hypotension with an exaggeration of the laryngeal chemoreflex in the absence of metabolic derangements or respiratory inhibition. In our studies the decrease in blood pressure was not associated with metabolic acidosis suggesting that there was no change in tissue perfusion. Additionally, since hypercapnia reversed the inhibition of the phrenic nerve and restored its activity to baseline levels, the exaggeration of SLN stimulation induced apnea following CGS administration can not be attributed to a non-specific inhibition caused by CGS, but rather to its ability to activate A 2A receptors.
Bicuculline reversed the effects of CGS on phrenic nerve response to SLN stimulation and produced a reflex response that was less inhibited when compared to control, pre-CGS level. The ability of bicuculline to attenuate SLN stimulation induced apnea in the absence of a significant increase in phrenic activity and/or CO 2 levels suggests that the bicuculline response was not secondary to a non-specific excitation, but rather to its ability to block GABA A receptors. Although bicuculline was administered almost two hours after CGS, there was continuing evidence of CGS effect in the form of persistent phrenic inhibition, hypotension and exaggerated phrenic depression in response to SLN stimulation just prior to administration of bicuculline. Therefore, the recovery of the phrenic activity and blood pressure following bicuculline administration was probably secondary to its ability to block the downstream effects of activation of A 2A receptors by CGS. Furthermore, although bicuculline blocked the phrenic inhibition produced by higher levels of SLN stimulation as compared to control, most of its effect was to reverse the exaggerated responses seen after CGS, signifying that bicuculline blocked the added effects of activation of adenosine A 2A receptors. The residual inhibition of the phrenic activity in response to higher levels of SLN stimulation might suggest the presence of GABA-independent mechanisms or the need for higher dose of bicuculline in the presence of CGS as a similar dose of bicuculline was able to block this response in the absence of CGS (1).
Adenosine has been implicated in the regulation of breathing and is known to depress neural function (7). It is ubiquitously released (by Na +-dependent transporters)
and is formed in the extracellular space by breakdown of released ATP (e.g., as a cotransmitter) and sequentially cleaved by ectoATPases/apyrases and ectonucleotidases. GABA is the major inhibitory neurotransmitter in the central nervous system. It was found to inhibit breathing mainly via activation of GABA A receptors (9, 11) . We have shown previously in newborn piglets that blocking GABA A receptors almost abolished apnea induced by SLN stimulation (1) . There is an increasing body of evidence of a central interaction between adenosine and GABA. We have previously reported that blockade of GABA A receptors abolishes the inhibitory effect of the adenosine A 2A agonist CGS on phrenic activity (34) . The adenosine A 2A receptor system appears to be one of the presynaptic neuromodulatory systems able to enhance the evoked release of GABA from hippocampal nerve terminals (3) and tuberomammillar nucleus in rats (13) .
Furthermore, anatomic studies have shown that A 2A receptors colocalize with GABAergic neurons in regions of the medulla oblongata in piglets (34) and developing rats (35) . These data as well as the ability of both theophylline and bicuculline to prevent the laryngeal reflex apnea point to the possible interaction between GABA and adenosine in the production of apnea during SLN stimulation. Our findings further expand these observations and allow for the speculation that SLN stimulation causes endogenous release of adenosine that activates A 2A receptors on GABAergic neurons resulting in the release of GABA at inspiratory neurons and subsequent respiratory inhibition.
Similar interaction between A 2A and GABA A receptors can be proposed to explain the effects of CGS and bicuculline on the blood pressure. Activation of adenosine A 2A receptors in the NTS as well as GABA A receptors in the rostral ventrolateral medulla (RVLM) have both been shown to cause hypotension and bradycardia through inhibition of sympathetic activity (20, (27) (28) (29) . Furthermore, blockade of GABA A receptors in the sympatho-excitatory region of the RVLM resulted in an increase in sympathetic activity and blood pressure (2, 27 and 31). These studies suggest a common pathway for hypotension induced by activation of GABA A and A 2A receptors through inhibition of sympathetic activity which is in agreement with our findings in vagotomized piglets. The ability of both CGS and bicuculline to regulate blood pressure despite vagotomy excludes a role for the parasympathetic, and implicates the sympathetic, system in this regulation.
Unlike previously mentioned studies in which CGS caused bradycardia in anesthetized animals, intracisternal CGS caused tachycardia in our animals. This could be related to vagotomy or to lack of the confounding effect of anesthesia on the heart rate response to CGS as was previously suggested. We speculate that SLN afferents activated during the laryngeal chemoreflex stimulate second order neurons in the NTS that release adenosine which in turn activates A 2A receptors on GABA containing neurons resulting in the release of GABA at inspiratory and sympathetic regions causing apnea and hypotension. The decrease in frequency was secondary to significant prolongation in expiratory time (T E ) associated with significant shortening of inspiratory time T I secondary to apnea.
* P value refers to the effect of increasing levels of stimulation on phrenic activity via one way ANOVA. Post-hoc multiple comparison analysis using Student Neuman-Keuls test revealed: ‡ P < 0.05 for all paired comparisons except between baseline and threshold and between 2x and 4x threshold. ‡ P< 0.05 for all paired comparisons except between baseline and threshold and between threshold and 1.5x threshold.
P< 0.05 only between 4x threshold and all other values. 
